Abstract:The excessive inflammation triggered by damage-associated molecular patterns (DAMPs) after myocardial infarction (MI) is responsible for the development of cardiac dysfunction and adverse remodeling, while the mechanisms by which inflammation is fine tuned remain to be fully elucidated. MicroRNA-21 (miR-21) has been shown to function in cardiovascular diseases, while its role in inflammatory responses and cardiac function post MI in mice remains unknown. Here, we found that miR-21 expression was markedly increased in border and infarct areas of cardiac tissues during the early inflammatory phase of MI model established by ligating the left-anterior descending coronary artery. MiR-21 knockout mice had decreased survival rates, worse cardiac dysfunction, and increased infarct and scar areas after MI compared with WT mice. MiR-21 knockout mice showed significantly higher levels of inflammatory cytokines including IL-1β, IL-6, and TNF-α in cardiac tissues, as well as infiltration of CD11b + monocytes/macrophages with higher expression level of inflammatory cytokines. MI induced the great release of high mobility group protein B1 (HMGB1) and heat shock protein 60 (HSP60) in cardiac tissue. MiR-21 deficiency significantly promoted the inflammatory cytokine production triggered by DAMPs in macrophages, whereas, miR-21 overexpression markedly inhibited the inflammatory cytokine production. Mechanistically, miR-21 deficiency enhanced p38 and NF-κB signaling activation in cardiac tissue post MI and macrophages treated with DAMPs. MiR-21 was found to directly target kelch repeat and BTB (POZ) domain containing 7 (KBTBD7), which promoted DAMP-triggered inflammatory responses in macrophages. Furthermore, KBTBD7 interacted with MKK3/6 and promoted their activation, which in turn enhanced the activation of downstream p38 and NF-κB signaling induced by DAMPs. Therefore, our findings demonstrate that miR-21 attenuates inflammation, cardiac dysfunction, and maladaptive remodeling post MI through targeting KBTBD7 and inhibiting p38 and NF-κB signaling activation, suggesting that miR-21 may function as a novel potential therapeutic target for MI.

miR‐16 exhibits protective function in LPS‐treated cardiomyocytes by targeting DOCK2 to repress cell apoptosis and exert anti‐inflammatory effect

The Regulatory Effect of Microrna-21A-3p on the Promotion of Telocyte Angiogenesis Mediated by PI3K (p110α)/akt/mtor in LPS Induced Mice ARDS

MiR-4763-3p Accelerates Lipopolysaccharide-Induced Cardiomyocyte Apoptosis and Inflammatory Response by Targeting IL10RA

MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7

Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice

The Modulation Effects of Lipopolysaccharide on Mir-211/Siert1 to Enhance Cardiomyocytes Apoptosis Induced by Hypoxia

miR-206 alleviates LPS-induced inflammatory injury in cardiomyocytes via directly targeting USP33 to inhibit the JAK2/STAT3 signaling pathway

Correction: Mir-206 Alleviates LPS-induced Inflammatory Injury in Cardiomyocytes Via Directly Targeting USP33 to Inhibit the JAK2/STAT3 Signaling Pathway

Suppression of microRNA-16 protects against acute myocardial infarction by reversing beta2-adrenergic receptor down-regulation in rats.

miR-203 accelerates apoptosis and inflammation induced by LPS via targeting NFIL3 in cardiomyocytes.

Long noncoding RNA NONHSAT122636.2 attenuates myocardial inflammation and apoptosis in myocarditis

LncRNA XIST Knockdown Reduces Myocardial Damage in Myocarditis by Targeting the Mir-140-3p/ripk1 Axis

Increased Expression of Microrna-146A Decreases Myocardial Ischaemia/reperfusion Injury

MicroRNA-22 Targeting CBP Protects Against Myocardial Ischemia–reperfusion Injury Through Anti-Apoptosis in Rats

Mir-197 Participates in Lipopolysaccharide-Induced Cardiomyocyte Injury by Modulating SIRT1

Suppression of lncRNA OIP5-AS1 Attenuates Apoptosis and Inflammation, and Promotes Proliferation by Mediating miR-25-3p Expression in Lipopolysaccharide-Induced Myocardial Injury

Luteolin Protects Cardiomyocytes Cells against Lipopolysaccharide-Induced Apoptosis and Inflammatory Damage by Modulating Nlrp3

Silencing DOCK2 Attenuates Cardiac Fibrosis Following Myocardial Infarction in Mice Via Targeting PI3K/Akt and Wnt/β-Catenin Pathways

Long non-coding RNA CDKN2B-AS1 enhances LPS-induced apoptotic and inflammatory damages in human lung epithelial cells via regulating the miR-140-5p/TGFBR2/Smad3 signal network

The Protective Role of MiR-206 in Regulating Cardiomyocytes Apoptosis Induced by Ischemic Injury by Targeting PTP1B

miR-708 affords protective efficacy in anoxia/reoxygenation-stimulated cardiomyocytes by blocking the TLR4 signaling via targeting HMGB1